Home/Filings/4/0001140361-24-002128
4//SEC Filing

Zaremba Rabourn Amy 4

Accession 0001140361-24-002128

CIK 0001228627other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 4:17 PM ET

Size

4.5 KB

Accession

0001140361-24-002128

Insider Transaction Report

Form 4
Period: 2024-01-10
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
  • Tax Payment

    Common Stock

    2024-01-10$3.27/sh3,950$12,89742,658 total

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001832343

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:17 PM ET
Size
4.5 KB